A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)

NCT01817803 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: furosemide/no spironolactone
DRUG: metolazone/no spironolactone
DRUG: furosemid/spironolactone
DRUG: metolazone/spironolactone

Sponsor

Yonsei University